Publications Database

Willemsen-Swinkels S. H. et al. (1999)

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Journal of Autism and Developmental Disorders

29(2), pp. 167-169

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behaviour in mentally retarded adults: double-blinded placebo-controlled studies.

Archives of General Psychiatry

52(9), pp. 766-773

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Placebo-controlled acute dosage naltrexone study in young autistic children.

Psychiatry Research

58(3), pp. 203-215

Read Abstract (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. (2002)

The autistic spectrum: subgroups, boundaries, and treatment.

Psychiatric Clinics of North America

25(4), pp. 811-836

Read Abstract (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. , van Engeland H. (1996)

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

Biological Psychiatry

39(12), pp. 1023-1031

Read Abstract (New Window)

Willey L. (1999)

Pretending to be normal: living with Asperger syndrome.

London: Jessica Kingsley Publishers

Williams T. I. (1989)

A social skills group for autistic children.

Journal of Autism and Developmental Disorders

19 pp. 43-55

Read Abstract (New Window)

Williams M. E. , Atkins M. , Soles T. (2008)

Assessment of autism in community settings: Discrepancies in classification.

Journal of Autism and Developmental Disorders

39(4), pp. 660-669

Read Abstract (New Window)

Williams P. G. et al. (2001)

Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.

Journal of Autism and Developmental Disorders

31(1), pp. 103-108

Read Abstract (New Window)

Williams K. J. et al. (2011)

Cochrane Review: Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

Evidence-Based Child Health: A Cochrane Review Journal

6(4), pp. 1044-1078

Read Abstract (New Window)

Williams K. R. , Wishart J. (2001)

Combining school attendance with home-based interventions for autism.

Journal of Research in Special Educational Needs

March, 1(1), pp. 13-16

Williams J. I. , Cram D. M. (1978)

Diet in the management of hyperkinesis: a review of the tests of Feingold's hypotheses.

Canadian Psychiatric Association Journal

23(4), pp. 241-248.

Read Abstract (New Window)

Williams C. et al. (2002)

Do children with autism learn to read more readily by computer assisted instruction or traditional book methods?

Journal of Autism and Developmental Disorders

6(1), pp. 71-91.

Read Abstract (New Window)

Williams D. (2009)

Exposure anxiety - the invisible cage. An exploration of self-protection responses in the autism spectrum and beyond.

London: Jessica Kingsley Publishers

Williams E. I. , Gleeson J. G. , Jones B. E.

How pupils on the autism spectrum make sense of themselves in the context of their experiences in a mainstream school setting: A qualitative metasynthesis.

Autism

Read Abstract (New Window)

Williams D. L. , Goldstein G. , Minshew N. J. (2005)

Impaired memory for faces and social scenes in autism: clinical implications of memory dysfunction.

Archives of Clinical Neuropsychology

20(1), pp. 1-15.

Read Abstract (New Window)

Williams K. J. , Wray J. A. , Wheeler D. M. (2012)

Intravenous secretin for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

4 CD003495.

Read Abstract (New Window) Read Full (New Window)

Williams D. (1988)

Like colour to the blind.

London: Jessica Kingsley Publishers

Williams K. J. , Marraffa C. (2012)

No evidence yet to support omega-3 fatty acids as a treatment for autism.

Journal of Pediatric Health Care

48(6), pp. 534-536.

Read Abstract (New Window)

Williams D. (1998)

Nobody nowhere.

London: Jessica Kingsley Publishers